Crackdown on Pharma Influence: Govt Bans Medical Reps from Central Hospitals
New Delhi: The Directorate General of Health Services (DGHS) under the Ministry of Health and Family Welfare has directed all central government hospitals to prohibit the entry of Medical Representatives (MRs) into their premises. The move is being widely viewed as a serious measure to curb undue pharmaceutical industry influence on prescribing practices, and aligns closely with the newly enforced Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024.
The directive, dated May 28, 2025, mandates that heads of institutions enforce this ban strictly and report compliance to the DGHS.
“This is in reference to the earlier instructions regarding not permitting entry of Medical Representative in hospital premises. In this regard it is once again instructed that the medical representatives should not be permitted in the hospital premises. The head of the institutions shall give necessary strict directions in the matter to all officials,” an order issued by Dr Sunita Sharma stated.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.